Trial Profile
Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Propagermanium (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 08 Jul 2015 New trial record